<SEC-DOCUMENT>0000886163-25-000042.txt : 20250702
<SEC-HEADER>0000886163-25-000042.hdr.sgml : 20250702
<ACCEPTANCE-DATETIME>20250702071018
ACCESSION NUMBER:		0000886163-25-000042
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		14
CONFORMED PERIOD OF REPORT:	20250702
ITEM INFORMATION:		Regulation FD Disclosure
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20250702
DATE AS OF CHANGE:		20250702

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			LIGAND PHARMACEUTICALS INC
		CENTRAL INDEX KEY:			0000886163
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		ORGANIZATION NAME:           	03 Life Sciences
		EIN:				770160744
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-33093
		FILM NUMBER:		251098324

	BUSINESS ADDRESS:	
		STREET 1:		3911 SORRENTO VALLEY BLVD
		STREET 2:		SUITE 110
		CITY:			SAN DIEGO
		STATE:			CA
		ZIP:			92121
		BUSINESS PHONE:		858-550-7500

	MAIL ADDRESS:	
		STREET 1:		3911 SORRENTO VALLEY BLVD
		STREET 2:		SUITE 110
		CITY:			SAN DIEGO
		STATE:			CA
		ZIP:			92121
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>lgnd-20250702.htm
<DESCRIPTION>8-K
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2025 Workiva-->
<!--r:c6bf0bcc-2ff3-4a9d-9b69-9e65a2df29f4,g:60ebfaf5-cf7f-429a-bba9-0f3fead04036,d:4dba0a3abf68462dac96cd9a8d50a96b-->
<html xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:dei="http://xbrl.sec.gov/dei/2025" xmlns="http://www.w3.org/1999/xhtml" xmlns:link="http://www.xbrl.org/2003/linkbase" xml:lang="en-US"><head><meta http-equiv="Content-Type" content="text/html"/>


<title>lgnd-20250702</title></head><body><div style="display:none"><ix:header><ix:hidden><ix:nonNumeric contextRef="c-1" name="dei:EntityCentralIndexKey" id="f-21">0000886163</ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="dei:AmendmentFlag" id="f-22">false</ix:nonNumeric></ix:hidden><ix:references xml:lang="en-US"><link:schemaRef xlink:type="simple" xlink:href="lgnd-20250702.xsd"/></ix:references><ix:resources><xbrli:context id="c-1"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2025-07-02</xbrli:startDate><xbrli:endDate>2025-07-02</xbrli:endDate></xbrli:period></xbrli:context></ix:resources></ix:header></div><div id="i4dba0a3abf68462dac96cd9a8d50a96b_1"></div><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:14pt;font-weight:700;line-height:173%">UNITED STATES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:14pt;font-weight:700;line-height:173%">SECURITIES AND EXCHANGE COMMISSION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:14pt;font-weight:700;line-height:173%">WASHINGTON, D.C. 20549</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:700;line-height:173%">______________</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:16pt;font-weight:700;line-height:173%">FORM <ix:nonNumeric contextRef="c-1" name="dei:DocumentType" id="f-1">8-K</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:700;line-height:173%">______________</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:173%">CURRENT REPORT</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:173%">Pursuant to Section 13 or 15(d) of the</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:173%">Securities Exchange Act of 1934</span></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:173%">Date of Report (Date of earliest event reported): <ix:nonNumeric contextRef="c-1" name="dei:DocumentPeriodEndDate" format="ixt:date-monthname-day-year-en" id="f-2">July 2, 2025</ix:nonNumeric> </span></div><div style="margin-bottom:7pt;margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:16pt;font-weight:700;line-height:173%"><ix:nonNumeric contextRef="c-1" name="dei:EntityRegistrantName" id="f-3">LIGAND PHARMACEUTICALS INC</ix:nonNumeric>ORPORATED</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:173%">     </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(Exact Name of Registrant as Specified in Its Charter)</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:86.538%"><tr><td style="width:1.0%"/><td style="width:32.233%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:32.233%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:32.234%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 2.12pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:EntityIncorporationStateCountryCode" format="ixt-sec:stateprovnameen" id="f-4">Delaware</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 2.12pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:EntityFileNumber" id="f-5">001-33093</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 2.12pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:EntityTaxIdentificationNumber" id="f-6">77-0160744</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 2.12pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">(State or other jurisdiction of</span></td><td colspan="3" style="padding:2px 2.12pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">(Commission File Number)</span></td><td colspan="3" style="padding:2px 2.12pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">(I.R.S. Employer</span></td></tr><tr><td colspan="3" style="padding:2px 2.12pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">incorporation or organization)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 2.12pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">Identification No.)</span></td></tr></table></div><div style="margin-bottom:7pt;margin-top:3pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:47.617%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.203%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:47.780%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 2.12pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:EntityAddressAddressLine1" id="f-7">555 Heritage Drive, Suite 200</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 2.12pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:EntityAddressCityOrTown" id="f-8">Jupiter</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 2.12pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:EntityAddressStateOrProvince" format="ixt-sec:stateprovnameen" id="f-9">Florida</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 2.12pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:EntityAddressPostalZipCode" id="f-10">33458</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 2.12pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">(Address of principal executive offices)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 2.12pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">(Zip Code)</span></td></tr></table></div><div style="margin-top:15pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:144%">(<ix:nonNumeric contextRef="c-1" name="dei:CityAreaCode" id="f-11">858</ix:nonNumeric>)&#160;<ix:nonNumeric contextRef="c-1" name="dei:LocalPhoneNumber" id="f-12">550-7500</ix:nonNumeric> </span></div><div style="margin-bottom:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:173%">(Registrant&#8217;s Telephone Number, Including Area Code)</span></div><div style="margin-bottom:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:173%">N/A</span></div><div style="margin-bottom:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:173%">(Former Name or Former Address, if Changed Since Last Report)</span></div><div style="text-align:center"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:173%">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:</span></div><div><span><br/></span></div><div style="padding-left:24.75pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:11pt;font-weight:400;line-height:144%"><ix:nonNumeric contextRef="c-1" name="dei:WrittenCommunications" format="ixt-sec:boolballotbox" id="f-13">&#9744;</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:144%">&#160;&#160;&#160;&#160;Written communications pursuant to Rule&#160;425 under the Securities Act (17 CFR 230.425)</span></div><div style="padding-left:24.75pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:11pt;font-weight:400;line-height:144%"><ix:nonNumeric contextRef="c-1" name="dei:SolicitingMaterial" format="ixt-sec:boolballotbox" id="f-14">&#9744;</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:144%">&#160;&#160;&#160;&#160;Soliciting material pursuant to Rule&#160;14a-12 under the Exchange Act (17 CFR 240.14a-12)</span></div><div style="padding-left:24.75pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:11pt;font-weight:400;line-height:144%"><ix:nonNumeric contextRef="c-1" name="dei:PreCommencementTenderOffer" format="ixt-sec:boolballotbox" id="f-15">&#9744;</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:144%">&#160;&#160;&#160;&#160;Pre-commencement communications pursuant to Rule&#160;14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</span></div><div style="padding-left:24.75pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:11pt;font-weight:400;line-height:144%"><ix:nonNumeric contextRef="c-1" name="dei:PreCommencementIssuerTenderOffer" format="ixt-sec:boolballotbox" id="f-16">&#9744;</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:144%">&#160;&#160;&#160;&#160;Pre-commencement communications pursuant to Rule&#160;13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Securities registered pursuant to Section 12(b) of the Ac</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">t:</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.878%"><tr><td style="width:1.0%"/><td style="width:37.797%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:20.293%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:38.610%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Title of each class</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trading Symbol(s)</span></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Name of each exchange on which registered</span></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:Security12bTitle" id="f-17">Common Stock, par value $0.001 per share</ix:nonNumeric></span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:TradingSymbol" id="f-18">LGND</ix:nonNumeric></span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="f-19">The Nasdaq Global Market</ix:nonNumeric></span></td></tr></table></div><div style="padding-left:24.75pt;text-indent:-22.5pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933(&#167;230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (&#167;240.12b-2 of this chapter).</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Emerging growth company  </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:11pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:EntityEmergingGrowthCompany" format="ixt-sec:boolballotbox" id="f-20">&#9744;</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#9744;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><div id="i4dba0a3abf68462dac96cd9a8d50a96b_7"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><div style="-sec-extract:summary;margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Item 7.01   Regulation FD Disclosure.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">On July 2, 2025, Ligand Pharmaceuticals Incorporated (&#8220;Ligand&#8221;) announced the closing of its previously announced Agreement and Plan of Merger (the &#8220;Merger Agreement&#8221;) pursuant to which Ligand&#8217;s wholly owned subsidiary, LNHC, Inc. (&#8220;LNHC&#8221;) merged with and into CHRO Merger Sub Inc., a wholly owned subsidiary of Channel Therapeutics Corporation (&#8220;Channel&#8221;), and became a wholly owned subsidiary of Channel (the &#8220;Transaction&#8221;). The combined company will operate under the name Pelthos Therapeutics Inc. (&#8220;Pelthos&#8221;), and will commence trading on the NYSE American exchange under the new ticker symbol &#8220;PTHS&#8221; on July 2, 2025. Ligand issued a press release announcing the closing of the Merger Agreement and certain other information regarding the Transaction. A copy of the press release is furnished with this Current Report on Form 8-K as Exhibit 99.1 and is incorporated herein by reference. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">In accordance with General Instruction B.2. of Form 8-K, the information in this Item 7.01 of this report, including Exhibit 99.1, shall not be deemed &#8220;filed&#8221; for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the &#8220;Exchange Act&#8221;), or otherwise subject to the liability of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth by specific reference in such a filing. </span></div><div><span><br/></span></div><div style="margin-bottom:6pt"><span><br/></span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Item 9.01.  Financial Statements and Exhibits. </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(d) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Exhibits</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:13.803%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.028%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:78.869%"/><td style="width:0.1%"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Exhibit No.</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Description</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"><a style="-sec-extract:exhibit;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:none" href="pelthosclosingv10_7125xfin.htm">99.1</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Press Release, dated July 2, 2025.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">104</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Cover Page Interactive Data File - the cover page XBRL tags are embedded within the Inline XBRL document.</span></td></tr></table></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Forward-Looking Statements</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">This report contains forward-looking statements, as defined in Section 21E of the Securities Exchange Act of 1934, regarding Ligand&#8217;s and Pelthos&#8217; current expectations. All statements, other than statements of historical fact, could be deemed to be forward-looking statements. In some instances, words such as &#8220;plans,&#8221; &#8220;believes,&#8221; &#8220;expects,&#8221; &#8220;anticipates,&#8221; and &#8220;will,&#8221; and similar expressions, are intended to identify forward-looking statements. Readers are cautioned not to place undue reliance on these forward-looking statements, which reflect our good faith beliefs (or those of the indicated third parties) and speak only as of the date hereof. These forward-looking statements include, without limitation, references to our expectations regarding (i) our belief that investors should feel encouraged that Pelthos has a strong development path towards successfully launching drugs with considerable market opportunities, (ii) the timing of clinical and regulatory events of us and our partners, (iii) the timing of the initiation or completion of preclinical studies and clinical trials by us and our partners, (iv) the timing of product launches, including ZELSUVMI, (v) guidance regarding projected financial results for 2025 and beyond, (vi) the anticipated benefits of the Transaction and (vii) the combined company&#8217;s opportunities, strategy and plans following the closing of the Transaction. These statements are not guarantees of future performance and are subject to certain risks, uncertainties and assumptions that are difficult to predict. Factors that could cause actual results to differ materially from those set forth in such forward-looking statements include, but are not limited to, risks and uncertainties related to there being no guarantee that the trading price of the combined company&#8217;s Common Stock will be indicative of the combined company&#8217;s value or that the combined company&#8217;s Common Stock will become an attractive investment in the future; we may rely on collaborative partners for milestone payments, royalties, materials revenue, contract payments and other revenue projections and may not receive expected revenue; we and our partners may not be able to timely or successfully advance any product(s) in our internal or partnered pipeline or receive regulatory approval and there may not be a market for the product(s) even if successfully developed and approved; and changes in general economic conditions, including as a result of war, conflict, epidemic diseases, the implementation of tariffs, and ongoing or future litigation could expose us to significant liabilities and have a material adverse effect on us. These and other risks and uncertainties are described more fully in our filings with the U.S. Securities and Exchange Commission. The information in this report is provided only as of the date of this report, and we undertake no </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">obligation to update any forward-looking statements contained in this report based on new information, future events, or otherwise, except as required by law.</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">SIGNATURES</span></div><div style="margin-bottom:20pt"><span><br/></span></div><div style="margin-bottom:20pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</span></div><div style="margin-bottom:20pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:95.993%"><tr><td style="width:1.0%"/><td style="width:40.970%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:56.830%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt 2px 3.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">LIGAND PHARMACEUTICALS INCORPORATED</span></td></tr><tr style="height:11pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date: July 2, 2025</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:2pt;margin-top:2pt;padding-left:38.25pt;padding-right:2.25pt;text-indent:-33.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By:   </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">/s/ Andrew Reardon        </span></div><div style="margin-bottom:2pt;margin-top:2pt;padding-left:38.25pt;padding-right:2.25pt;text-indent:-33.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Name:    Andrew Reardon</span></div><div style="margin-bottom:2pt;margin-top:2pt;padding-left:38.25pt;padding-right:2.25pt;text-indent:-33.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Title:   Chief Legal Officer and Secretary </span></div></td></tr></table></div><div style="margin-top:9pt"><span><br/></span></div><div style="margin-bottom:12pt;text-indent:36pt"><span><br/></span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>pelthosclosingv10_7125xfin.htm
<DESCRIPTION>EX-99.1
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2025 Workiva -->
<title>Document</title></head><body><div id="icfdb433e9d3f48c3a6be46ccc54c65db_1"></div><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:8pt"><img alt="image_0.jpg" src="image_0.jpg" style="height:62px;margin-bottom:5pt;vertical-align:text-bottom;width:178px"></div><div style="margin-bottom:8pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:14pt;font-weight:700;line-height:134%">Ligand Announces Completion of Pelthos Therapeutics Merger with Channel Therapeutics</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">Pelthos plans to launch ZELSUVMI&#8482; for the treatment of Molluscum contagiosum infections in July 2025</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">Concurrent with the closing of the merger, Ligand has invested $18 million in the combined company and is entitled to a 13% royalty on worldwide sales of ZELSUVMI</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">Pelthos will commence trading on the NYSE American exchange under the new ticker symbol &#8220;PTHS&#8221; on July 2, 2025</font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">JUPITER, Fla., July 2, 2025 &#8211; Ligand Pharmaceuticals Incorporated (Nasdaq&#58; LGND) today announced the completion of its previously announced merger between</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">the company&#8217;s wholly owned subsidiary, LNHC, Inc., and CHRO Merger Sub Inc., a wholly owned subsidiary of Channel Therapeutics Corporation (&#8220;Channel&#8221;). The combined company will operate under the name Pelthos Therapeutics Inc. (&#8220;Pelthos&#8221;) and will commence trading on the NYSE American exchange under the new ticker symbol &#8220;PTHS&#8221; on July 2, 2025.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8220;Today marks not just a corporate milestone, but a transformative turning point for the team at Pelthos,&#8221; said Todd Davis, CEO of Ligand. &#8220;With the successful closing of this merger and the launch of Pelthos as an independent, publicly traded biopharmaceutical company, we have unlocked new potential for innovation and long-term value creation for our shareholders. This moment is the result of the vision, hard work, and unwavering commitment of our internal team, who developed the commercial platform to help bring ZELSUVMI, a novel product addressing a significant unmet need, to market this summer. Ligand recognized the potential value of ZELSUVMI before it was approved, during a time when others did not, and we are proud to bring this impactful treatment to market through our special situations initiatives.&#8221;</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Concurrent with the merger, Pelthos raised $50.1 million of equity capital, including a private placement from a group of strategic investors led by Murchinson (&#8220;Investor Group&#8221; and together with Ligand, the &#8220;Investors&#8221;). The Investor Group invested $32 million and Ligand invested $18 million in the combined company, respectively. The capital is being invested into Pelthos&#8217; Series A Convertible Preferred Stock (&#8220;Series A&#8221;) and Common Stock and includes cancellation of approximately $18.8 million in bridge capital that was advanced to Pelthos by several of the Investors (including Ligand) since the beginning of 2025 to support the commercial launch of ZELSUVMI. Ligand is entitled to a 13% royalty on worldwide net sales of ZELSUVMI. </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8220;Ligand has been an incredible partner over the past few years, and we look forward to their continued guidance and support as members of the Pelthos board,&#8221; commented Scott Plesha, CEO of Pelthos. &#8220;We are excited to begin this new chapter as a publicly traded company and to bring this innovative product to the patients who need it.&#8221;</font></div><div style="text-align:justify"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Pelthos will initially focus on the launch and  commercialization of ZELSUVMI (berdazimer) topical gel, 10.3%, for the treatment of </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">Molluscum contagiosum</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> infections (&#8220;molluscum&#8221;)  in adults and pediatric patients one year of age and older.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7.15pt;font-weight:400;line-height:120%;position:relative;top:-3.85pt;vertical-align:baseline">1</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> ZELSUVMI is an FDA-designated novel drug and the first and only prescription medication approved for the treatment of molluscum that can be administered at home by parents, patients, and caregivers. Molluscum is a poxvirus and one of the most common skin infections seen by dermatologists, pediatric dermatologists, and pediatricians, afflicting an estimated 16.7 million people in the United States.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7.15pt;font-weight:400;line-height:120%;position:relative;top:-3.85pt;vertical-align:baseline">2,3</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Additionally, Pelthos is continuing to evaluate the path forward for Channel&#8217;s existing NaV 1.7 development programs for the treatment of various types of chronic pain, acute and chronic eye pain, and post-surgical nerve blocks. </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Latham &#38; Watkins LLP served as lead counsel to Ligand. </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:120%">About Ligand Pharmaceuticals</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Ligand is a biopharmaceutical company enabling scientific advancement through supporting the clinical development of high-value medicines. Ligand does this by providing financing, licensing our technologies or both. Our business model seeks to generate value for stockholders by creating a diversified portfolio of biotech and pharmaceutical product revenue streams that are supported by an efficient and low corporate cost structure. Our goal is to offer investors an opportunity to participate in the promise of the biotech industry in a profitable and diversified manner. Our business model is based on funding programs in mid- to late-stage drug development in return for economic rights, purchasing royalty rights in development stage or commercial biopharmaceutical products and licensing our technology to help partners discover and develop medicines. We partner with other pharmaceutical companies to attempt to leverage what they do best (late-stage development, regulatory management and commercialization) in order to generate our revenue. We operate two infrastructure-light royalty generating technology IP platform technologies. Our Captisol&#174; platform technology is a chemically modified cyclodextrin with a structure designed to optimize the solubility and stability of drugs. Our NITRICIL&#8482; platform technology facilitates tunable dosing, permitting an adjustable drug release profile to allow proprietary formulations that target a broad range of indications. We have established multiple alliances, licenses and other business relationships with the world&#8217;s leading pharmaceutical companies including Amgen, Merck, Pfizer, Jazz, Gilead Sciences and Baxter International. For more information, please visit </font><font style="color:#467886;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">www.ligand.com</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. Follow Ligand on </font><font style="color:#467886;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">X</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> and </font><font style="color:#467886;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">LinkedIn</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">We use our investor relations website and X as a means of disclosing material non-public information and for complying with our disclosure obligations under Regulation FD. Investors should monitor our website and our X account, in addition to following our press releases, SEC filings, public conference calls and webcasts.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Forward-Looking Statements </font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">This press release contains forward-looking statements, as defined in Section 21E of the Securities Exchange Act of 1934, regarding Ligand and Pelthos&#8217; current expectations. All statements, other than statements of historical fact, could be deemed to be forward-looking </font></div><div style="border-bottom:0.54pt solid #000000;margin-bottom:5pt;margin-top:10pt;opacity:1;width:144pt"></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">1</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Aptos',san-serif;font-size:8pt;font-weight:400;line-height:120%">Please see ZELSUVMI&#8482; (berdazimer) topical gel full prescribing information available at </font><font style="color:#467886;font-family:'Aptos',san-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline">https&#58;&#47;&#47;www.fda.gov&#47;drugsatfda</font><font style="color:#000000;font-family:'Aptos',san-serif;font-size:8pt;font-weight:400;line-height:120%"> for important safety information or </font><font style="color:#467886;font-family:'Aptos',san-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline">www.zelsuvmi.com</font></div><div><font style="color:#000000;font-family:'Aptos',san-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">2</font><font style="color:#000000;font-family:'Aptos',san-serif;font-size:8pt;font-weight:400;line-height:120%"> US Census Bureau. QuickFacts&#58; United States.2022. </font><font style="color:#467886;font-family:'Aptos',san-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline">https&#58;&#47;&#47;www.census.gov&#47;quickfacts&#47;fact&#47;table&#47;US&#47;PST045222</font><font style="color:#000000;font-family:'Aptos',san-serif;font-size:8pt;font-weight:400;line-height:120%"> </font></div><div><font style="color:#000000;font-family:'Aptos',san-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">3</font><font style="color:#000000;font-family:'Aptos',san-serif;font-size:8pt;font-weight:400;line-height:120%"> Hebert AA, et al. J Clin Aesthet Dermatol. 2023 Aug&#59;16(8 Suppl 1)&#58;S4-S11</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">statements. In some instances, words such as &#8220;plans,&#8221; &#8220;believes,&#8221; &#8220;expects,&#8221; &#8220;anticipates,&#8221; and &#8220;will,&#8221; and similar expressions, are intended to identify forward-looking statements. Readers are cautioned not to place undue reliance on these forward-looking statements, which reflect our good faith beliefs (or those of the indicated third parties) and speak only as of the date hereof. These forward-looking statements include, without limitation, references to our expectations regarding (i) our belief that investors should feel encouraged that Pelthos has a strong development path towards successfully launching drugs with considerable market opportunities, (ii) the timing of clinical and regulatory events of us and our partners, (iii) the timing of the initiation or completion of preclinical studies and clinical trials by us and our partners, (iv) the timing of product launches, including ZELSUVMI, (v) guidance regarding projected financial results for 2025 and beyond, (vi)   the anticipated benefits of the merger between Pelthos and Channel and (vii) the combined company&#8217;s opportunities, strategy and plans following the merger. These statements are not guarantees of future performance and are subject to certain risks, uncertainties and assumptions that are difficult to predict. Factors that could cause actual results to differ materially from those set forth in such forward-looking statements include, but are not limited to, risks and uncertainties related to there being no guarantee that the trading price of the combined company&#8217;s Common Stock will be indicative of the combined company&#8217;s value or that the combined company&#8217;s Common Stock will become an attractive investment in the future&#59; we may rely on collaborative partners for milestone payments, royalties, materials revenue, contract payments and other revenue projections and may not receive expected revenue&#59; we and our partners may not be able to timely or successfully advance any product(s) in our internal or partnered pipeline or receive regulatory approval and there may not be a market for the product(s) even if successfully developed and approved&#59; and changes in general economic conditions, including as a result of war, conflict, epidemic diseases, the implementation of tariffs, and ongoing or future litigation could expose us to significant liabilities and have a material adverse effect on us. These and other risks and uncertainties are described more fully in our filings with the U.S. Securities and Exchange Commission. The information in this press release is provided only as of the date of this press release, and we undertake no obligation to update any forward-looking statements contained in this press release based on new information, future events, or otherwise, except as required by law.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Contacts</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Investors&#58;<br>Melanie Herman</font></div><div style="text-align:justify"><font style="color:#467886;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">investors&#64;ligand.com</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%"><br>(858) 550-7761</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Media&#58; <br>Kellie Walsh</font></div><div style="text-align:justify"><font style="color:#467886;font-family:'Aptos',san-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">media&#64;ligand.com</font><font style="color:#000000;font-family:'Aptos',san-serif;font-size:12pt;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%"><br>(914) 315-6072</font></div><div style="text-align:justify"><font><br></font></div><div style="margin-bottom:8pt;text-align:justify"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>3
<FILENAME>lgnd-20250702.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2025 Workiva-->
<!--r:c6bf0bcc-2ff3-4a9d-9b69-9e65a2df29f4,g:60ebfaf5-cf7f-429a-bba9-0f3fead04036-->
<xs:schema xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:lgnd="http://www.ligand.com/20250702" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://www.ligand.com/20250702">
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/dei/2025" schemaLocation="https://xbrl.sec.gov/dei/2025/dei-2025.xsd"/>
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="lgnd-20250702_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="lgnd-20250702_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>
      <link:roleType id="CoverPage" roleURI="http://www.ligand.com/role/CoverPage">
        <link:definition>0000001 - Document - Cover Page</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>4
<FILENAME>lgnd-20250702_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2025 Workiva-->
<!--r:c6bf0bcc-2ff3-4a9d-9b69-9e65a2df29f4,g:60ebfaf5-cf7f-429a-bba9-0f3fead04036-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel"/>
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:label id="lab_dei_SolicitingMaterial_d19ec49a-9e59-43a9-85ef-17c67942220c_terseLabel_en-US" xlink:label="lab_dei_SolicitingMaterial" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Soliciting Material</link:label>
    <link:label id="lab_dei_SolicitingMaterial_label_en-US" xlink:label="lab_dei_SolicitingMaterial" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Soliciting Material</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SolicitingMaterial" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SolicitingMaterial"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SolicitingMaterial" xlink:to="lab_dei_SolicitingMaterial" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_WrittenCommunications_17986f70-d35b-4eb4-9401-7ceda5637a04_terseLabel_en-US" xlink:label="lab_dei_WrittenCommunications" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Written Communications</link:label>
    <link:label id="lab_dei_WrittenCommunications_label_en-US" xlink:label="lab_dei_WrittenCommunications" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Written Communications</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_WrittenCommunications" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_WrittenCommunications"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_WrittenCommunications" xlink:to="lab_dei_WrittenCommunications" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LocalPhoneNumber_2ccf1039-f1a6-469f-9f1d-3123b39de147_terseLabel_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Local Phone Number</link:label>
    <link:label id="lab_dei_LocalPhoneNumber_label_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Local Phone Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_LocalPhoneNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LocalPhoneNumber" xlink:to="lab_dei_LocalPhoneNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CoverAbstract_266378a9-e26b-4e8a-9612-ec4bf3ba1658_terseLabel_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cover page.</link:label>
    <link:label id="lab_dei_CoverAbstract_label_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CoverAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CoverAbstract" xlink:to="lab_dei_CoverAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentPeriodEndDate_0d123f0b-8a3c-46e2-b305-e290b494c0db_terseLabel_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Period End Date</link:label>
    <link:label id="lab_dei_DocumentPeriodEndDate_label_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Period End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentPeriodEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentPeriodEndDate" xlink:to="lab_dei_DocumentPeriodEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_PreCommencementTenderOffer_b59a92d5-ee1d-44a6-a2ec-d89e59b37f21_terseLabel_en-US" xlink:label="lab_dei_PreCommencementTenderOffer" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
    <link:label id="lab_dei_PreCommencementTenderOffer_label_en-US" xlink:label="lab_dei_PreCommencementTenderOffer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementTenderOffer" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementTenderOffer"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_PreCommencementTenderOffer" xlink:to="lab_dei_PreCommencementTenderOffer" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_7b6ecc62-0359-4872-a0c8-2a815a8dd31e_terseLabel_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_label_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CurrentFiscalYearEndDate" xlink:to="lab_dei_CurrentFiscalYearEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AmendmentFlag_e68aa019-66a1-4ddc-9496-26f114a76dc9_terseLabel_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Amendment Flag</link:label>
    <link:label id="lab_dei_AmendmentFlag_label_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Amendment Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AmendmentFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AmendmentFlag" xlink:to="lab_dei_AmendmentFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCentralIndexKey_d600cbf7-ed9c-4a79-b28a-b941dd61db39_terseLabel_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:label id="lab_dei_EntityCentralIndexKey_label_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCentralIndexKey"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCentralIndexKey" xlink:to="lab_dei_EntityCentralIndexKey" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_PreCommencementIssuerTenderOffer_f912d410-d629-43aa-8d0f-a109961cfd60_terseLabel_en-US" xlink:label="lab_dei_PreCommencementIssuerTenderOffer" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
    <link:label id="lab_dei_PreCommencementIssuerTenderOffer_label_en-US" xlink:label="lab_dei_PreCommencementIssuerTenderOffer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementIssuerTenderOffer" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementIssuerTenderOffer"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_PreCommencementIssuerTenderOffer" xlink:to="lab_dei_PreCommencementIssuerTenderOffer" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_217a69a8-17a3-4918-85a9-43f63b7e6b00_terseLabel_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_label_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityTaxIdentificationNumber" xlink:to="lab_dei_EntityTaxIdentificationNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_928f9fa4-c10a-40aa-b03e-9c45b353d6e7_terseLabel_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_label_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityEmergingGrowthCompany" xlink:to="lab_dei_EntityEmergingGrowthCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFileNumber_d4ade6c0-c45f-45c0-a45c-c2ee2d931974_terseLabel_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity File Number</link:label>
    <link:label id="lab_dei_EntityFileNumber_label_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity File Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityFileNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFileNumber" xlink:to="lab_dei_EntityFileNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityRegistrantName_1d5d49bc-4171-4b89-a204-2ac5869251b8_terseLabel_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:label id="lab_dei_EntityRegistrantName_label_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityRegistrantName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityRegistrantName" xlink:to="lab_dei_EntityRegistrantName" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SecurityExchangeName_894f236f-7113-4bfb-b5d1-c1b56ea195ee_terseLabel_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Security Exchange Name</link:label>
    <link:label id="lab_dei_SecurityExchangeName_label_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Security Exchange Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SecurityExchangeName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SecurityExchangeName" xlink:to="lab_dei_SecurityExchangeName" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_TradingSymbol_b21692ce-ff9c-4829-986f-fc885f803e3d_terseLabel_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Trading Symbol</link:label>
    <link:label id="lab_dei_TradingSymbol_label_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trading Symbol</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_TradingSymbol"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_TradingSymbol" xlink:to="lab_dei_TradingSymbol" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_cf74d9d2-a213-41e3-83d4-2b29d1b4f3b7_terseLabel_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_label_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityIncorporationStateCountryCode" xlink:to="lab_dei_EntityIncorporationStateCountryCode" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_Security12bTitle_4eab0965-f0fc-437c-b1a6-202fa710903b_terseLabel_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:label id="lab_dei_Security12bTitle_label_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Security12bTitle"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_Security12bTitle" xlink:to="lab_dei_Security12bTitle" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressStateOrProvince_4054a2f3-9756-4cfc-9347-6428711f8871_terseLabel_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:label id="lab_dei_EntityAddressStateOrProvince_label_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressStateOrProvince"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressStateOrProvince" xlink:to="lab_dei_EntityAddressStateOrProvince" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressPostalZipCode_d9bb4786-fec6-44da-918f-d01c762a9c36_terseLabel_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:label id="lab_dei_EntityAddressPostalZipCode_label_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressPostalZipCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressPostalZipCode" xlink:to="lab_dei_EntityAddressPostalZipCode" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressCityOrTown_34c54d90-d26b-4211-b053-a59ea5be076d_terseLabel_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:label id="lab_dei_EntityAddressCityOrTown_label_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressCityOrTown"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCityOrTown" xlink:to="lab_dei_EntityAddressCityOrTown" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine1_82862876-06de-48dd-a95c-47254228546d_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine1_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine1" xlink:to="lab_dei_EntityAddressAddressLine1" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentType_1bf5ac76-ed12-4b10-8b40-a19b46b8844d_terseLabel_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Type</link:label>
    <link:label id="lab_dei_DocumentType_label_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Type</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentType"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentType" xlink:to="lab_dei_DocumentType" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CityAreaCode_17469a6c-a702-4a7a-916a-16c45e270d7d_terseLabel_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">City Area Code</link:label>
    <link:label id="lab_dei_CityAreaCode_label_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">City Area Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CityAreaCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CityAreaCode" xlink:to="lab_dei_CityAreaCode" xlink:type="arc" order="1"/>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>5
<FILENAME>lgnd-20250702_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2025 Workiva-->
<!--r:c6bf0bcc-2ff3-4a9d-9b69-9e65a2df29f4,g:60ebfaf5-cf7f-429a-bba9-0f3fead04036-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.ligand.com/role/CoverPage" xlink:type="simple" xlink:href="lgnd-20250702.xsd#CoverPage"/>
  <link:presentationLink xlink:role="http://www.ligand.com/role/CoverPage" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract_732a9325-e62f-4493-b421-59c9db47bc8a" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CoverAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_e62d2a09-b1d8-4c91-96f3-ba697bb566d2" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCentralIndexKey"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_732a9325-e62f-4493-b421-59c9db47bc8a" xlink:to="loc_dei_EntityCentralIndexKey_e62d2a09-b1d8-4c91-96f3-ba697bb566d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_3606f8ab-b402-4258-93b7-aad602cf9673" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AmendmentFlag"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_732a9325-e62f-4493-b421-59c9db47bc8a" xlink:to="loc_dei_AmendmentFlag_3606f8ab-b402-4258-93b7-aad602cf9673" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate_8f402a59-d347-45cc-9dab-99781a8db5e1" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_732a9325-e62f-4493-b421-59c9db47bc8a" xlink:to="loc_dei_CurrentFiscalYearEndDate_8f402a59-d347-45cc-9dab-99781a8db5e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_385d4e8a-d4e6-4265-b55c-993f9dc35c9e" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentType"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_732a9325-e62f-4493-b421-59c9db47bc8a" xlink:to="loc_dei_DocumentType_385d4e8a-d4e6-4265-b55c-993f9dc35c9e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_450693f1-05a5-4aca-a806-c001886bf0f2" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentPeriodEndDate"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_732a9325-e62f-4493-b421-59c9db47bc8a" xlink:to="loc_dei_DocumentPeriodEndDate_450693f1-05a5-4aca-a806-c001886bf0f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_fe76f004-7fdf-4f14-b9cd-8eb914ff657c" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityRegistrantName"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_732a9325-e62f-4493-b421-59c9db47bc8a" xlink:to="loc_dei_EntityRegistrantName_fe76f004-7fdf-4f14-b9cd-8eb914ff657c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_65adbe0c-96e1-4273-8481-1e088db8412a" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_732a9325-e62f-4493-b421-59c9db47bc8a" xlink:to="loc_dei_EntityIncorporationStateCountryCode_65adbe0c-96e1-4273-8481-1e088db8412a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_7c8f0622-5e44-4484-bbe3-fe148d29a44c" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityFileNumber"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_732a9325-e62f-4493-b421-59c9db47bc8a" xlink:to="loc_dei_EntityFileNumber_7c8f0622-5e44-4484-bbe3-fe148d29a44c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_851eedb1-d918-410a-83aa-88a30ab1ddcf" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_732a9325-e62f-4493-b421-59c9db47bc8a" xlink:to="loc_dei_EntityTaxIdentificationNumber_851eedb1-d918-410a-83aa-88a30ab1ddcf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_964eae74-ea50-4449-bb68-6b56935fd65f" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine1"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_732a9325-e62f-4493-b421-59c9db47bc8a" xlink:to="loc_dei_EntityAddressAddressLine1_964eae74-ea50-4449-bb68-6b56935fd65f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_3c635912-67b0-43a3-960a-d88f109b08e3" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressCityOrTown"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_732a9325-e62f-4493-b421-59c9db47bc8a" xlink:to="loc_dei_EntityAddressCityOrTown_3c635912-67b0-43a3-960a-d88f109b08e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince_95ba25b6-89c3-4b1a-b131-0f5cf3460069" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressStateOrProvince"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_732a9325-e62f-4493-b421-59c9db47bc8a" xlink:to="loc_dei_EntityAddressStateOrProvince_95ba25b6-89c3-4b1a-b131-0f5cf3460069" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_7ff40bcd-608e-4049-bdc1-64b88a299078" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressPostalZipCode"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_732a9325-e62f-4493-b421-59c9db47bc8a" xlink:to="loc_dei_EntityAddressPostalZipCode_7ff40bcd-608e-4049-bdc1-64b88a299078" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_dc0efa23-7324-43d4-a6f1-e7c99e4c687a" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CityAreaCode"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_732a9325-e62f-4493-b421-59c9db47bc8a" xlink:to="loc_dei_CityAreaCode_dc0efa23-7324-43d4-a6f1-e7c99e4c687a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_ed12e889-8bb2-439b-932e-db206ec33620" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_LocalPhoneNumber"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_732a9325-e62f-4493-b421-59c9db47bc8a" xlink:to="loc_dei_LocalPhoneNumber_ed12e889-8bb2-439b-932e-db206ec33620" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_WrittenCommunications_e3f583a8-86b4-4430-9799-3f1f6ae5d9e9" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_WrittenCommunications"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_732a9325-e62f-4493-b421-59c9db47bc8a" xlink:to="loc_dei_WrittenCommunications_e3f583a8-86b4-4430-9799-3f1f6ae5d9e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SolicitingMaterial_eb458e20-a2d7-46ef-b2aa-16d6a68bf30b" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SolicitingMaterial"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_732a9325-e62f-4493-b421-59c9db47bc8a" xlink:to="loc_dei_SolicitingMaterial_eb458e20-a2d7-46ef-b2aa-16d6a68bf30b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementTenderOffer_e014f675-ea58-43e7-8930-24490c9627fe" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementTenderOffer"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_732a9325-e62f-4493-b421-59c9db47bc8a" xlink:to="loc_dei_PreCommencementTenderOffer_e014f675-ea58-43e7-8930-24490c9627fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementIssuerTenderOffer_6d709a42-e4f4-4366-bb8f-f780d5950e73" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementIssuerTenderOffer"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_732a9325-e62f-4493-b421-59c9db47bc8a" xlink:to="loc_dei_PreCommencementIssuerTenderOffer_6d709a42-e4f4-4366-bb8f-f780d5950e73" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_b88d6a8e-b9d6-49db-8756-210116daf0e7" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Security12bTitle"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_732a9325-e62f-4493-b421-59c9db47bc8a" xlink:to="loc_dei_Security12bTitle_b88d6a8e-b9d6-49db-8756-210116daf0e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_ec984bc8-6acb-4fde-b608-26303907cdc0" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_TradingSymbol"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_732a9325-e62f-4493-b421-59c9db47bc8a" xlink:to="loc_dei_TradingSymbol_ec984bc8-6acb-4fde-b608-26303907cdc0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_fb605efb-7897-4510-a949-198eebc43cac" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SecurityExchangeName"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_732a9325-e62f-4493-b421-59c9db47bc8a" xlink:to="loc_dei_SecurityExchangeName_fb605efb-7897-4510-a949-198eebc43cac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_a8c24e2d-576b-408b-9a1c-a4edfdcbffe8" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_732a9325-e62f-4493-b421-59c9db47bc8a" xlink:to="loc_dei_EntityEmergingGrowthCompany_a8c24e2d-576b-408b-9a1c-a4edfdcbffe8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>6
<FILENAME>image_0.jpg
<TEXT>
begin 644 image_0.jpg
MB5!.1PT*&@H    -24A$4@   9$   "," (    R? /Q     7-21T( KLX<
MZ0    1G04U!  "QCPO\804    )<$A9<P  (=4  "'5 02<M)T  "\G241!
M5'A>[9U[F"15>?_Y\_?\=*?KUCV7!0PF!EEA9[I.5<_"BMQ,C!K!!&5O<^WN
MJK[,<%$P*B(Q:KRBQF@23 CW6QY$!;(04*YB4'Y(!)4[&D!6V5UNNS/3757G
M\GN^IV87MKN9[MZ>G9W>Y\Q^GK.SM5W5W56GOO6>][SG?0^RW&+/T'C"SEM.
MV7)\TRF83E&A4"B6&V\^<GR%73CH34>5>NV)56O'AHZ?/.J$\54G*10*Q7+$
M2F],V/Y!NNL?=<*ZD'$N:"BXX%3P:,^VYI_MM@TWMMXVW-AZVW!CZVW#C:VW
M#3>VWC;<V'K;<&/K;<.-;;4--[;>-MS8>MMP8^MMPXVMMPTW[FY9W9:V=F_:
M-MS8>MMP8^MMPXVMMPTWHGW[B1.]P\6#=.>,HX[?R#D7+!0<TJ50*/8IL T4
M[?..=X\F2>$@W2VO.G%35>P^CYQ#N10*A6)Y\8YWCUBD?)#A%E:=.,8YA6 )
MQB/\+XNHV/4TB']1*!2*?0X#C#%H#ZW]WR-/&DV2\D&F4UAUXKB 5D&S&%[)
M(_P=OXPJ% K%DA#%OU3I7,0KG 5BSY_&FA4Q%C+VQ+-;KKSQ1U?>>,>5-]Y^
MY8UW*A0*Q1)PE6POO_&.R[Y_QY//_+XES9+C0?X?M]QED:SF% V2-XEG$K^#
MMN'&UMN&&UMO&VYLO6VXL?6VX<;6VX8;6V\;;FR];;BQK;;AQM;;AAM;;QMN
M;+UMN+'UMN'&W6VA;DM;NS=M&VYLO6VXL?6VX<;FK8'3 L'1G6+2GKQB\X];
MTRP1:];=NE/L<:=UQ].=@D*A4.Q[2KKC:ZZG.5-).WO%S7>WI%GP8?'HVEON
MEFKG6R0GGPD*A6+1L.JV*'!:[)+A>"8IFJ24M/UK-K>F61@;BNC:6^XQB:\[
M!8L4Y6H>A4*AV,>0@N9Z!BF93LX@):59"H5B>:,T2Z%0=!-*LQ0*13>A-$NA
M4'032K,4"D4WH31+H5!T$TJS% I%-Z$T2Z%0=!-*LQ0*13>A-$NA4'032K,4
M"D4WH31+H5!T$TJS% I%-Z$T2Z%0=!-*LQ0*13>A-$NA4'032K,4"D4WH31+
MH5!T$TJS% I%-Z$T2Z%0=!-*LQ0*13>A-$NA4'032K,4"D4WH31+H5!T$TJS
M% I%-Z$T2Z%0=!-*LQ0*13>A-$NA4'032K,4"D4WH31+H5!T$TJS% I%-Z$T
M2Z%0=!-*LQ0*13>A-$NA4'032K,4"D4W<8!J5DEW"J8[83I^3\;3'<]T"CHH
M6G:I[L7[%LTMF:1@.$7=\2Q23)(<?G=S%BD9;A[_6[=+._@FSG_)(B435]&W
MG$FT;MER"KT9S[#S9MJW2-&R"Y93-)R23HJZ732=DN'(7>R"X19UUS/<"=,=
MU]R"AK-7EH?%>=MW&+*UG+QF^QH^?R%)?'S"=-%(%_0E>'=2M'!IRB8I)>V\
MX>:3=MFRR[KC&6XN/K=[C45*NILWG6P2;^$G;;R=X?@6\4U21/]L!\O)::ZG
M93R=H!MK;DLGQWI=W\")=4NZZYMNUG)R^"_'LW!K^+I;N^.RYD#4+'D9\$O.
MLD_72<$@94@5\0PG9^[C.Z$!LM,89$IS?<V91H=SIC0W;Y+3Y4?M3+,(!-IT
M?,/-&F[.<#S#GM8<3Q_.:VXAD2X;PR4-G3*O.5G#S>HD:[F>Y>2MC*\[GN;D
M\:G<DN9.Z^1TTRY;Q+.(O*^@MO.RLH_8=7"_Q_9UXEEV5G<+NNN9]J29SFIN
M:1^_NV\Z>1UGH-#C%A.90@)7IZ3A09*W[*(\MWM/$C(!?3%).>&"'K>@9?(&
M+KJG._GZ719"'@TGQ"X9T+Z"Z1070)^GA,[F3%DDGR0Y$_\$.IY8K[^X':GS
M4G.@:A8,*_3^J3Y[8Z^=!60TZ8PF<,&6]M/*IUR2Y/N=#PV0#0/DPP-D0Z^S
MSB)ET_7,#D\==H?5IF>RNIO7'5_#+UZ2Y'O3XW\T/#GUJ:]=><,=CSSWXBN1
MV"E$A8LY+K;-A+]X\OE+OWO+&>=_9]4)Q3Z<F0GL[OK2Z("%I3M>3V;?:E:,
MX11Z'"])1OSS_LT[_]^*YUTX=>ZW"^=?LB*=W:?O+K_IM&7[_>FQ 7M3'QGM
M)YN29$1SLPFWF$S#[JO?JW62MC3V2;&/;.HG'^ZSQP?LC7WV* Z+QU5[SRJ=
MG)%T)GKM\92=2Y'Q))DT85"_(?WVIGY[M,\>[R79),EI>!A Q4Q8^O'=$9M=
M^!C2VJI]Q^7+@:A9L4QX>B9G.9/;HB@2+!2"<E'EXH^<T\QV'W&= =O!\8\X
M/E=E(N0B$CQDXMF79Y-D$J9^IP+JFZZGN[Y&BI8SE;2G>M/^GZ[-7O;]NV8I
M#[G@7 @N!!.",\$BP)G@#-<1%Y%'G%6YN//!IT[QOY0B(QKQ,%3$(]HW,3ZJ
M?\=%1-X\^&7RHU^X/!""<XI/Q]D<%X<=/;Y/G__2T,BM.?FL@ O&6"1$0-F.
M2!SJCEN9DNYT.C8T24ES<[UV]E4N0LXH%XSSJA KR7K+\7327B?\XS6C<X)3
MRD,A0AQ)7KXW)N"\PODL%[-"O# 37/^C^\_\NW\_;'ACBHSJ)(][%K9>49?&
MK-7A-UUB#E#-*EC$UX9+9GKRU2!B(HIP/X2A$/W.AZ4A5K?+OD,Z((X\?IR)
MB',60;7HEI=FDDY6<^':J'U]>\0#X;)!"E9Z9.C/_8>??+[*11B%'"(5"U,,
MD[PF8M Q+@05G#+*6,#8G."?_,K%??8ZW?5U.>2L>[O%)7[@%\STQFVS@6"S
M@D>""49G*:>WW_>T*2V"?81N%W52/.:4<Q@5@E+*!8V"2G7V\=^]E!H:D2/'
MVEW: YJ5[QTJ[.2<04"$8'B7E<ZHX90-N^[U"W+8,?F*8#P*(R$B$>(2+OS#
M!:>R"U!!J:!A1",>4O%R*+YYU7\=XJSOL\?T=':79M6^W;+FP-0LJ4J&6S32
M^;F0RD\K\)02;"7YZ[H7[V.D _Z(XW,,?5=0* 7_PTLSIN-)-W#=ZQ<D'FY(
M)ZXOOZ:7(+[AEOO(NEOO^V40Q=^4H9\R%C%I0.">E$2[?HD5"Q\()@9G5-I?
M4#/&Z(Y(G#SYV9233[C3!BDFX""7\QB+?97EW(AO.N4/%O\>LLD#?#39M1@/
M&!-]9"R1*1CVI!F/LQ;Y8>,E2#YSRIG0;A')ZR(HJU+!+_GN3[3!'.Q-.V_"
M=UZ2[J?VWMT@D..D[<W(*PXQYC048L!9+[]U>W;66X\MLEB!\'$CP="70EAO
MD7SN1/'_[6XY8US^X&^Y)_["O^7YY>+^7SUSQ$F^1K)20$NF=(;&[Q7/62U?
M#F#-LF#\Y^<B&EL60O:;E<ZI=2_>YQA.X? 3?'P,Z (^S+879^1D37M.C7DG
M'1PBOB:]5PF<^?S1)Y_U2HAG.&>X,:!.&.]0P:H!I8$05<%G.)\1?*?@.SB;
MX3S@&#E2[,$XA44FC3%.*654A$+<]O-?)^WQ%4>-]JS.X:-BTJ#VPW2(YG@&
M*:;L_%,OS @11#0V"N/>A3^?_?;WWT3R>CHK5:.XV':?EW!*PR?'FA6;HYSB
M\H0AYR=L.B?IE SBZ;B9_;T8PNNNI[G%I).MR+[',:3#B5U)-M:_N"EO.;8@
M/Q[&]?($12QD$02(R<<@A>_C=3!X($+. BX"C"9W.03D0R&28W!>Y>*&NW_9
M.[3>L/,&*9KNA $EE7.+=1]@&:$T:PG8K5GQ3R>:I67PB)8SWYCO,QVO<.YW
M CQJ*:-1@)Z*?X1!4.7BN9>H_\E_676\WT_&+2>/& OHG9=,C_<-KGOG*6>?
M_[6K7ZK ,0_1FC>^,$1BO#(;5'>&(D5&C*$L)LLQN;[([JT$\1)NR?ZS F6,
MP@38943,=[&HPH4QN GS7%#JML]5,^HU2]J@M,IYM2K$X<?GC"%,1/0,3\AW
M;Z^3-]2L8)$T*^3\VLWW77W+ U???-_5-S]PU<T_O?;F^U_/U?]YW_=_^.##
M3V^?Y;B^T@4V?XDA>#@*%]$<CX*92+CO*YHV+JX&(ZNT%]UR25&:M00LIF;-
M1T[YECO5E\E]XLM75BG#2(KBV2E$R%@4"7[/_4\>>5RA;WA:CNGP 72W8+AY
M P[[>* G!R^.9Z3'WGK,Q'6W_;S*1$2K$:MP'O$ 8P_&Z>KWGVT,P<S!*5UT
ME[R+"+6?/O0;P>"F@>U Z4P8P1Q!%ZMR03>6OVPB?"QGP<I;W&Y6KUGSSCZ,
M$IEX-1+]@YL2]G1/)F<ZV;K=F[!/-6L6GMEQPRD9;E8Z"N K>#W2@5"P2*[7
MGDC9(^GWG/4W7[AD3DZYP U 112%^ M6&7P&'_G"O_<-3AGD]!7VF.4N[GE>
M;)1F+0&+.#:,Y4-W"BG'SYW]]2I\JQ78*;&_(N([ O'VX\9[['Q/NIBR2QHI
M&P@E1>BFY8Q;SH3E9*7SHJ"3LN;X/6XAF3F[CY3^Y)@-O_[]]KDP]H!$%28^
M\K<7_=]5ZQ.#>4W.3BZZ1]P@A;<=,Q9$<!?+,0N;Y<(Y,5?!6 :&%V>L2EG2
MG9"W7^WN'5.K65*WI)TJ_V8\^M]MK_;9X_#'0Z_;\_(TU*S%&AM6A#C8'K7L
M:<O)6O"XU9) S!WN;1F"E]?L2<LNI0:+Z3^;?GS+]H#C08<A8BS0G%89/^^"
MJP:&<XGTI&:W+=!+BM*L)6 1[2P+'H>LYGI'O6<Z8(*R  Z-D')>"5EPS_\\
MD[)'381K%8U,P219]&E$TF+N$A$Z<9#.? QTSB)YD^0U9U)W<R8I&T/ED>*7
MJHQ3'EY[R\^L=%ZWXQT+".EN?WRT,(:=OW;S3V@4WSF4"KYQ^HLK[>+O=\S!
M^<)@ T0T?/L)D\GYD.#:(W1&K6;)CQ'!$2\-$1ZP@(D++KXI2;(:KM3\=]_E
MVVHB8?M:L_J=4=TIZ9DL/)L8N>\!KB\"[GW++F)H[Y1Z['S"S9FNUV\7UK[_
M(U4<"8$W\X$O(:WP\/2_OS )UV'\[>(ON)A7?'%0FK4$+*)F89%-VK/(Q Y8
M5J&,5X /*V+TRAONM>SQ^EW:H9C,E ]_Y^B3V\3![@;-QCAT<9%WEY]R2JE,
M*97>-"ND)PX&(CS*O>ZHYA;737T&JAG-87: 1R_,5+35$SUV$XUHGUK-JD01
MI_3E"H9-$9?#519&7!SQK@F\7B[TF5^,A35234;*^U2S B%ZB:>Y/B2FM74\
MK\=PO)7N^*^>_D-$ \K"B,5SZ_#D#9[DO=F>Q#H-.$!C7\0BV]>=HC1K"5C,
ML6%F2G?\2[YW%^4BI)&<'81W]6>//&<X?B_IR*K7'6]%>M)(^RDRU7?TZ2OL
MB44(4]H30]Y@!BE93NY+%WXWY"*(J@C+X.'??_O:I%/4,U.'D'PEGL#C412$
M<U0</+3.S)RYV'/PM9H5AM6 B8'TARH<OKUX'H#Q8([SOL%UFIO38*>T&O2P
MG#4KZ>3[UDR;)/NCG_X24XY41AI+Y]9.+@YQQK1Y?P*.O.Q6(RK-6@(6T<ZR
MG,*A:_-5A!-5(GA=0D[Y3LI,9U(N#^S<,L*\/@8=&!2T?3,LC [G+H*P#:?4
M:Y\6R A7!-E&K,)HRIG0<:OXYNJI;UYV$V(PY,GB//SMUI>2^$B+^WEJ-8MS
M41%"&YX\[H-G,\R^5K"0 #%UT?:Y:M(>U9Q2SY O9V"Q&J;N@'O04+,6RP??
MH6;)]=)YS2WVNL4['WB$11&#DP'3."&;>7J+Z%M3ZEU[IG0@9+'NI^X(^Q.E
M64O (MI9*6?ROQ_90N6D#V9\. LY/_($+/2U[#C0M':7ML#P!]9$5@9D+?)E
MU9V2],=YNN-[?_/U78]V^%,VW_N0X9;Q;"=>3[IPR)H-(9SP0GY%1!+U#2[Z
MA:O5+"I$P(5VM&>N+MUTSV.AG-B06L;#*/S)+YX;<+(KTB4+R2?V4K.6B9TE
M8QI\PYW0UDSUVA/;YB)$O6+N!2%=$1=O6SMFNE["+J20AF2W"V]YH#1K">C,
MSHIE:%Z,#EN;#1&XCO&@])Y&5]U\GXDD*J?+A"KUN[?'ZV^ O;@9%D9S2A:R
M"WAZ>GP&L4)4\*K@K,+$42?E=7?*D$N+WT2R5F;J%X^](#M;%7<J#VY_\!G9
MS7:?C4[5N5ZS(D$IY^;P5,+U^C*EQY^9%9A#K83H.IQ1.O6W_])C8T)#SFDT
MN7;+6;,LNR1E-V>D"\;0Y*''%L)(H$_Q*H]$Q*LS7%C.Q JGG"3Q?/%RNL&5
M9BT!'6D69ME+AC.IVZ6>0>]K%UX7KS*!QX4%%28.S6RT[&DYJ9>/E^DO6Q)K
M"KV#GIGQWSOYV7A6$%$-(7_X=]MZW2FY4A>)O7#M,G[_VF(UFI-KD" <<U3T
M$S_A3& ^5.:W:JH:S:C5++D0ALL/X&$8:X]C70S'8@$86RRJA/#'&S;2D]4=
MK9;EK%EU>#?<_2#GU4#:ME!H+E;:I^KD(TBVA<?,<KK!E68M 9V,#74WC_1;
M\O+T.?DJAE*RZV)L2#??]6 OF3#=*;E^;;EK%G*'I7.66_C=JY@]D"M/PHBQ
MXS]TCF$7=(0%P7HRB*^3G$YROY^IX%OR*(*K7GSQHINMM&>XTS(BO_.4&$TT
MRU@]WD\VP+$E4TT$Z/K17"A6KADWADM-\[=TD6;I3J$W_:$PP@@Q%FC&V,7?
MO\_$.L0LLLYU>JH7%:592T G=I9,AE4TW9SEE@X_-B<70:/WXW;G8NTI']5D
M *$TQY:[9B5EJH/T^S^&C#,(+L.:Y&V5J)_D]8R<GW(]N4@H'O<5DX.G8/@K
MH^09HZ^$=&!U5A^:DDE$XS"B3FBB64EW^DV#8^-G?1U#6(;E,OA_QI[<\F*O
M.Y' 0H*%QJ<--6N9^.!KD+,BWB^>^%^Y0AU+J06C,UST$P1_:;B;EM,-KC1K
M">C$SM(R?M(N(@&I4_RP=YX\A!0N%LUQT9<>DZDUY[]R4\?P_L6R"YH]^O\>
M?5ZFD< %"868_-BWX!["HJ+BO&;-WX1P?LWB)L451!P7C\;/^'J2(,9U,>ZB
M)IJ%1*EN5G,G;[OWD4CFO9 3M4C=<]6-]VOIB<300B%:#35KV=I9FE/Z\XV?
ME /#.#D7"P1?::_7W*)6]_K]C-*L): 3.ZLGX_?:18/X"=N[_:=/R.FM.*E(
M]6>//INR98IDUX]S?FM8&5=[A.6#;GO]F1'&0L0$P5*LOAJQ7GM<<\K&?)S]
MZTVMHFF73EKW$9GN069 B_@+,W-F&JNFY6LZ['5--$LZVN%K[\WDM^X(9+_'
MPF+*PH")TTI?U-)Y+?V&*66Z2+.D;'D#SKA,SL7A=I FY1%K1Q%3NMSN;J59
M2T GFJ5A2;-OD**6]N;D-Y'?AS,67'#);=9K0:1O> DP243\'I+5;3D'U Y)
M C5)V$49E-2V3"0Q.850+Z29E_FJ+KWN3L8#N4P&*1@_^T_7Z'BCLD4:E/-
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<2TPG;Y+"_P>ZX.\V)8?#:     !)14Y$KD)@@@$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>8
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Cover Page<br></strong></div></th>
<th class="th"><div>Jul. 02, 2025</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0000886163<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Jul.  02,  2025<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">LIGAND PHARMACEUTICALS INC<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-33093<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">77-0160744<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">555 Heritage Drive, Suite 200<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Jupiter<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">FL<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">33458<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">858<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">550-7500<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock, par value $0.001 per share<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">LGND<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14a<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>9
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
.report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

.report table.authRefData a {
	display: block;
	font-weight: bold;
}

.report table.authRefData p {
	margin-top: 0px;
}

.report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

.report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

.report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

.report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
.pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
.report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

.report hr {
	border: 1px solid #acf;
}

/* Top labels */
.report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

.report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

.report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

.report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

.report td.pl div.a {
	width: 200px;
}

.report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
.report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
.report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
.report .re, .report .reu {
	background-color: #def;
}

.report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
.report .ro, .report .rou {
	background-color: white;
}

.report .rou td {
	border-bottom: 1px solid black;
}

.report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
.report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
.report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

.report .nump {
	padding-left: 2em;
}

.report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
.report .text {
	text-align: left;
	white-space: normal;
}

.report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

.report .text .more {
	display: none;
}

.report .text .note {
	font-style: italic;
	font-weight: bold;
}

.report .text .small {
	width: 10em;
}

.report sup {
	font-style: italic;
}

.report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.25.2</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>22</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="lgnd-20250702.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>0000001 - Document - Cover Page</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ligand.com/role/CoverPage</Role>
      <ShortName>Cover Page</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" isOnlyDei="true" original="lgnd-20250702.htm">lgnd-20250702.htm</File>
    <File>lgnd-20250702.xsd</File>
    <File>lgnd-20250702_lab.xml</File>
    <File>lgnd-20250702_pre.xml</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="22">http://xbrl.sec.gov/dei/2025</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>14
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "lgnd-20250702.htm": {
   "nsprefix": "lgnd",
   "nsuri": "http://www.ligand.com/20250702",
   "dts": {
    "inline": {
     "local": [
      "lgnd-20250702.htm"
     ]
    },
    "schema": {
     "local": [
      "lgnd-20250702.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "https://www.xbrl.org/dtr/type/2024-01-31/types.xsd",
      "https://xbrl.sec.gov/dei/2025/dei-2025.xsd"
     ]
    },
    "labelLink": {
     "local": [
      "lgnd-20250702_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "lgnd-20250702_pre.xml"
     ]
    }
   },
   "keyStandard": 22,
   "keyCustom": 0,
   "axisStandard": 0,
   "axisCustom": 0,
   "memberStandard": 0,
   "memberCustom": 0,
   "hidden": {
    "total": 2,
    "http://xbrl.sec.gov/dei/2025": 2
   },
   "contextCount": 1,
   "entityCount": 1,
   "segmentCount": 0,
   "elementCount": 24,
   "unitCount": 0,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2025": 22
   },
   "report": {
    "R1": {
     "role": "http://www.ligand.com/role/CoverPage",
     "longName": "0000001 - Document - Cover Page",
     "shortName": "Cover Page",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "lgnd-20250702.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "lgnd-20250702.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://www.ligand.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Amendment Flag",
        "label": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "CityAreaCode",
     "presentation": [
      "http://www.ligand.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "City Area Code",
        "label": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cover page.",
        "label": "Cover [Abstract]",
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "dei_CurrentFiscalYearEndDate": {
     "xbrltype": "gMonthDayItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "CurrentFiscalYearEndDate",
     "presentation": [
      "http://www.ligand.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Current Fiscal Year End Date",
        "label": "Current Fiscal Year End Date",
        "documentation": "End date of current fiscal year in the format --MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://www.ligand.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Period End Date",
        "label": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentType",
     "presentation": [
      "http://www.ligand.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Type",
        "label": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://www.ligand.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, Address Line One",
        "label": "Entity Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://www.ligand.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, City or Town",
        "label": "Entity Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://www.ligand.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, Postal Zip Code",
        "label": "Entity Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://www.ligand.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, State or Province",
        "label": "Entity Address, State or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://www.ligand.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Central Index Key",
        "label": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://www.ligand.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Emerging Growth Company",
        "label": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://www.ligand.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity File Number",
        "label": "Entity File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://www.ligand.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Incorporation, State or Country Code",
        "label": "Entity Incorporation, State or Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://www.ligand.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Registrant Name",
        "label": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://www.ligand.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Tax Identification Number",
        "label": "Entity Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://www.ligand.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Local Phone Number",
        "label": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "PreCommencementIssuerTenderOffer",
     "presentation": [
      "http://www.ligand.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Pre-commencement Issuer Tender Offer",
        "label": "Pre-commencement Issuer Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "dei_PreCommencementTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "PreCommencementTenderOffer",
     "presentation": [
      "http://www.ligand.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Pre-commencement Tender Offer",
        "label": "Pre-commencement Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "Security12bTitle",
     "presentation": [
      "http://www.ligand.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Title of 12(b) Security",
        "label": "Title of 12(b) Security",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://www.ligand.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Security Exchange Name",
        "label": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_SolicitingMaterial": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "SolicitingMaterial",
     "presentation": [
      "http://www.ligand.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Soliciting Material",
        "label": "Soliciting Material",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "TradingSymbol",
     "presentation": [
      "http://www.ligand.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Trading Symbol",
        "label": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "dei_WrittenCommunications": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "WrittenCommunications",
     "presentation": [
      "http://www.ligand.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Written Communications",
        "label": "Written Communications",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r1": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r2": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14a",
   "Subsection": "12"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "425"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>15
<FILENAME>0000886163-25-000042-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0000886163-25-000042-xbrl.zip
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MI(=Y@V H7-;'/9U=\#C),G*;5VD3=NL*:695-B^->G<DG#LJ[>01V"2P(6#
M:Q ^L('PPPFBCB^1(JQE_,8\Z2.3RIA)+*QS@21)R&(Y3OV$!R),8W_*8O""
M8V]*/;,.X0 (D<41])!JGJA)81S%>##-WWG@OH83[(=VDL384]S90+$-Y%S:
M? Q?>$G'KIO-F2J6 3KM'<.VL?Q@>]8[!1KY[',@'1!2]JF_:0&J7UH TL;;
M*\S?P>$"DF,X+@VR2$.\:EX.PM ?<*!? JLX4ZJUTLDO/[>;]?K1)NOGA;F/
MD-=[QNJ_&:I C2*N+"I4*-RDOM"-ZW8CXR!DG4+Z'[/^!]4FZ[Z_87;-,J'A
M9FG]Z_!)/P2C!B@0##^!+",0VS))_9MBDCF>;)PANH%#JG4.9D6!218*0V8L
M4K=,W?)[X))K)5"38-TM%8BA+E=7GH>&V';<TOBFN 7P-9P"PMOIEFK=->R#
MP=OM>$>W_0ZYIQ?'J5!/X*'#[X&':L*H'SC;\5#6=I6'7IP25%Q3V$VUO284
M6'S1NDI!$I/,?CMUOL[R?9&-">ADU53,02B6N4=A+!'TCA(^Q]#'2N'[/+M"
M+HLU[\('<>BGR6J7+]7*ZW]':JX2AL(8@,MW9W /J-OA_H1/8PRFO%R%_LNF
MDMHML]7<O0BJ:3;;NV62-@UE6Z;=?J8BJ)9Y6/V/4DD9N6E+ /9FP%?29;F0
M9&\IAK3RLAA7J[ZBNIX5J20^O<6S5;IRU1DQQ^=QO$6(\?LAC^(4_NE/QX/0
M/]@J_KH5<92>Y*],N[SVDSA+Y'LK;$J3D80G\YUKETA_1I],LVVDWU^?,W?P
M/+6U,*W: Y+VF9G7+)V@N0@KTD]"YZ[,(J[8/?=3P?X;ZPJJ+,)S>Z.GE3C^
M6*F=5RK3-EK9S):I53JY^'!YMJ\E^ XTU>ZRE+L*^B3!LE>%RFXQC5QMPUX"
M)O@ECUW^+_;!#\'K8I^XNA/)EQ.?&Y-9.[JNKR7&3?Y +W#111-L,&4.Q;O!
M:KV#S4%04>=2,%K&#$ $_PX-VR$;JG"2C-#3BS! S6/F"@^FH!,%Z.2QNM7(
M_9ZEX*,^<E0[0#^P>40AR+PMS +K&N%1!,PXT$"@-@U[S5#KCC&Q?%!T&N?]
M"L.:N\7+][,TYQO(S';T'Y\M#F(_I>H@Q^(#(='5.&P9 K&MUQ8"(1*L9EI?
M(??TO$=$M0P"NE;NY4K^:012+7SAX%4G04AAC306U K6/<MRX;T>Y/PS?4X?
MEY?F\J<X.5V1@JP; &[P1HE[&4,_T!4\<) [N>/@Z0]LC#=JN%RYL<YON9MB
M*K4#/HNI%+6 N6<!F3'LOMG LF;ANOT#LT%P7EGL:?O+(IJSRR+V&*]"S6F
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ML,*]5 4R'LWO3H-GW50IG#,[RH^*(B^KX6CEC^1 )JS=-JN:#;'&IB"+ )P
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MO+T2.[VB?T>5?GSUY/\!4$L#!!0    ( $@YXEK\>X#[8@(    '   1
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M*&]5\$=>?,N^L^!RQDJ=%W, SJJWG>=W3T5V<UL&*$3Q9MGFU>*U(%R'7 B
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M7B1VA!T-Q_W6ZDSV6.TQ$=X7A0GV(5N:(?/?BA6;C_J$$R4$02",["F_-$&
MA2(%B*4P9JF4$52]A\,=(L>>$U>RP4HWL,(>G7!GA7K,D ?P[3A.^EAV&RWW
M>/*;,G<%'6_@W&.K,7ON6^N.X3M#M+14?YBQFZDB*6,AI( 0!@&64@"**0&(
M: @Q2X@4M"][C<A'!NY9*[!B_1%KNM_/E;<G-YAZVG'"IS5U+V::D48#I=5
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MJU?_!U!+ 0(4 Q0    ( $@YXEIK[0\+K!4  (MX   1              "
M 0    !L9VYD+3(P,C4P-S R+FAT;5!+ 0(4 Q0    ( $@YXEK\>X#[8@(
M   '   1              "  =L5  !L9VYD+3(P,C4P-S R+GAS9%!+ 0(4
M Q0    ( $@YXEI8@:48?@H  /]8   5              "  6P8  !L9VYD
M+3(P,C4P-S R7VQA8BYX;6Q02P$"% ,4    " !(.>):5^:)5N0&  #],@
M%0              @ $=(P  ;&=N9"TR,#(U,#<P,E]P<F4N>&UL4$L! A0#
M%     @ 2#GB6NN NN!T$P  _$H  !X              ( !-"H  '!E;'1H
M;W-C;&]S:6YG=C$P7S<Q,C5X9FEN+FAT;5!+!08     !0 % % !  #D/0
"   !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>16
<FILENAME>lgnd-20250702_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xml:lang="en-US"
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2025"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="lgnd-20250702.xsd" xlink:type="simple"/>
    <context id="c-1">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
        </entity>
        <period>
            <startDate>2025-07-02</startDate>
            <endDate>2025-07-02</endDate>
        </period>
    </context>
    <dei:EntityCentralIndexKey contextRef="c-1" id="f-21">0000886163</dei:EntityCentralIndexKey>
    <dei:AmendmentFlag contextRef="c-1" id="f-22">false</dei:AmendmentFlag>
    <dei:DocumentType contextRef="c-1" id="f-1">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="c-1" id="f-2">2025-07-02</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName contextRef="c-1" id="f-3">LIGAND PHARMACEUTICALS INC</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="c-1" id="f-4">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="c-1" id="f-5">001-33093</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="c-1" id="f-6">77-0160744</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="c-1" id="f-7">555 Heritage Drive, Suite 200</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown contextRef="c-1" id="f-8">Jupiter</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="c-1" id="f-9">FL</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="c-1" id="f-10">33458</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="c-1" id="f-11">858</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="c-1" id="f-12">550-7500</dei:LocalPhoneNumber>
    <dei:WrittenCommunications contextRef="c-1" id="f-13">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="c-1" id="f-14">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="c-1" id="f-15">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="c-1" id="f-16">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle contextRef="c-1" id="f-17">Common Stock, par value $0.001 per share</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="c-1" id="f-18">LGND</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="c-1" id="f-19">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany contextRef="c-1" id="f-20">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
